一位住院COVID-19患者的新出现的面部损伤
Emelie E Nelson1, Morgan A Rousseau1, Cassandra A Mohr1
1Dermatology, John P. and Kathrine G. McGovern Medical School at UTHealth, Houston, USA.
Cureus
|June 5, 2023
概括
这份病例报告详细介绍了一名COVID-19患者的罕见面部压力,尽管经常轮换床位. 它强调了在专业治疗期间需要意识到非典型压力的位置.
科学领域:
- 医学 医学 医学 医学 医学
- 伤口护理 伤口护理
- 关键的护理关键的护理
背景情况:
- 压力通常发生在卧床患者中,由于长时间的皮肤压缩,特别是在骨突出处.
- 预防措施,如定期重新定位,对于减轻压力发育的风险至关重要.
- 住院患者,尤其是行动能力有限的患者,面临这些并发症的重大风险.
相关概念视频
Endocarditis II: Clinical Features of Infective Endocarditis
14
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
14
Pneumonia III: Complications and Assessment
287
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
287
Pneumonia IV: Management
402
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
402
Acute Respiratory Failure-III
235
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
235
Acute Respiratory Failure-II
291
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
291
Acute Respiratory Failure-I
254
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
254


